R87.811
Vaginal high risk human papillomavirus (HPV) DNA test positive
Clinical Classification Guidelines
Medical Intelligence & Overview
A positive result on a vaginal high-risk human papillomavirus (HPV) DNA test indicates the presence of high-risk HPV types in the vaginal area. HPV is a common sexually transmitted infection, and certain high-risk strains are associated with a higher likelihood of developing cervical and other types of cancers. This test helps identify women at increased risk for cervical abnormalities, enabling closer monitoring and early intervention if necessary.
Causes & Symptoms
Clinical Causes: Unprotected sexual activity with an HPV-infected partner Multiple sexual partners Weakened immune system, which may reduce HPV clearance Previous HPV infection that persists or reactivates Smoking, which can impair immune response Other sexually transmitted infections that may increase susceptibility
Key Symptoms: Often none; HPV infections are frequently asymptomatic Formation of genital warts in some cases, although not always linked to high-risk strains Abnormal cervical cell changes detectable during Pap tests Possible itching or irritation in the vaginal area (less common)
Diagnostic & Treatment
Diagnosis Path: The primary method for detecting high-risk HPV is through a molecular DNA test performed on samples collected from the vaginal or cervical area. When the test returns positive, healthcare providers may recommend further evaluations such as Pap smears (Pap tests) to examine cervical cells for abnormalities. In some cases, colposcopy — a detailed examination of the cervix using a special magnifying device — might be necessary to assess the extent of any cellular changes.
Treatment Protocols: Monitoring with regular Pap tests and HPV testing to observe whether the infection clears on its own Procedures to remove abnormal tissues or lesions, such as cryotherapy, loop electrosurgical excision procedure (LEEP), or laser therapy, if cervical abnormalities are detected Addressing any co-existing infections or risk factors, like smoking cessation Patient education on sexual health practices to reduce transmission
Clinical Advice & FAQs
Billing Guidance
Is R87.811 a billable ICD-10 code?
Yes, R87.811 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report R87.811?
Clinical documentation must specify the nature of Vaginal high risk human papillomavirus (HPV) DNA test positive and any associated comorbidities for accurate reporting.
Cite this Clinical Reference